• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses

tetano

Editor, Senior Moderator
Cell Discov. 2019 Apr 16;5:21. doi: 10.1038/s41421-019-0086-x. eCollection 2019.
[h=1]Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses.[/h] Xiao H[SUP]#[/SUP][SUP]1,[/SUP][SUP]2[/SUP], Guo T[SUP]#[/SUP][SUP]1,[/SUP][SUP]2[/SUP], Yang M[SUP]#[/SUP][SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Qi J[SUP]2,[/SUP][SUP]3[/SUP], Huang C[SUP]1,[/SUP][SUP]2[/SUP], Hong Y[SUP]4[/SUP], Gu J[SUP]1,[/SUP][SUP]5[/SUP], Pang X[SUP]1,[/SUP][SUP]2[/SUP], Liu WJ[SUP]6[/SUP], Peng R[SUP]2,[/SUP][SUP]3[/SUP], McCauley J[SUP]7[/SUP], Bi Y[SUP]2,[/SUP][SUP]3[/SUP], Li S[SUP]2,[/SUP][SUP]3[/SUP], Feng J[SUP]1,[/SUP][SUP]2[/SUP], Zhang H[SUP]1,[/SUP][SUP]2,[/SUP][SUP]5[/SUP], Zhang X[SUP]1,[/SUP][SUP]2[/SUP], Lu X[SUP]1,[/SUP][SUP]2[/SUP], Yan J[SUP]8[/SUP], Chen L[SUP]9[/SUP], Shi Y[SUP]2,[/SUP][SUP]3[/SUP], Chen W[SUP]4[/SUP], Gao GF[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The isolation of human monoclonal antibodies with broadly neutralizing breadth can provide a promising countermeasure for influenza A viruses infection. Most broadly neutralizing antibodies against influenza A viruses bind to the conserved stem region or the receptor-binding cavity of hemagglutinin and the interaction is dominated by the heavy chain. The light chain, however, contributes few or no direct contacts to the antigen. Here we report an H3-clade neutralizing human monoclonal antibody, AF4H1K1, which recognizes the hemagglutinin glycoproteins of all group 2 influenza A viruses. This human monoclonal antibody has been obtained through the screening by pairing different heavy and light chains from an H7N9-infected patient based on the next-generation sequencing technology. Further structural studies revealed that light chains modulate the neutralizing spectrum by affecting the local conformation of heavy chains, instead of direct interaction with the antigen. These findings provide important clues to understand the molecular basis of light chains in antigen recognition and to explore the strategies in particular of the use of light chain modification to develop broadly protective monoclonal antibodies against influenza A viruses and other emerging viruses.


PMID: 30993000 PMCID: PMC6465249 DOI: 10.1038/s41421-019-0086-x
Free PMC Article
 
Back
Top Bottom